A Systems Approach Identifies Essential FOXO3 Functions at Key Steps of Terminal Erythropoiesis.

PLoS Genet

Department of Developmental & Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America; Developmental and Stem Cell Biology Multidisciplinary Training Area, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America; Department of Medicine, Division of Hematology, Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.

Published: October 2015

Circulating red blood cells (RBCs) are essential for tissue oxygenation and homeostasis. Defective terminal erythropoiesis contributes to decreased generation of RBCs in many disorders. Specifically, ineffective nuclear expulsion (enucleation) during terminal maturation is an obstacle to therapeutic RBC production in vitro. To obtain mechanistic insights into terminal erythropoiesis we focused on FOXO3, a transcription factor implicated in erythroid disorders. Using an integrated computational and experimental systems biology approach, we show that FOXO3 is essential for the correct temporal gene expression during terminal erythropoiesis. We demonstrate that the FOXO3-dependent genetic network has critical physiological functions at key steps of terminal erythropoiesis including enucleation and mitochondrial clearance processes. FOXO3 loss deregulated transcription of genes implicated in cell polarity, nucleosome assembly and DNA packaging-related processes and compromised erythroid enucleation. Using high-resolution confocal microscopy and imaging flow cytometry we show that cell polarization is impaired leading to multilobulated Foxo3-/- erythroblasts defective in nuclear expulsion. Ectopic FOXO3 expression rescued Foxo3-/- erythroblast enucleation-related gene transcription, enucleation defects and terminal maturation. Remarkably, FOXO3 ectopic expression increased wild type erythroblast maturation and enucleation suggesting that enhancing FOXO3 activity may improve RBCs production. Altogether these studies uncover FOXO3 as a novel regulator of erythroblast enucleation and terminal maturation suggesting FOXO3 modulation might be therapeutic in disorders with defective erythroid maturation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599908PMC
http://dx.doi.org/10.1371/journal.pgen.1005526DOI Listing

Publication Analysis

Top Keywords

terminal erythropoiesis
20
terminal maturation
12
foxo3
9
functions key
8
key steps
8
terminal
8
steps terminal
8
nuclear expulsion
8
enucleation terminal
8
enucleation
6

Similar Publications

PLK1 inhibition impairs erythroid differentiation.

Front Cell Dev Biol

December 2024

School of Life Sciences, Zhengzhou University, Zhengzhou, China.

Polo-like kinase 1 (PLK1), a key regulator of the G2/M phase in mitosis, is frequently overexpressed in numerous tumors. Although PLK1 inhibitors have emerged as promising therapeutic agents for cancer, their use has been linked to significant anemia in a subset of patients, yet the underlying mechanisms remain poorly understood. In this study, we utilized an human umbilical cord blood-derived CD34 cell-based erythroid differentiation system, alongside a murine model, to investigate the impact of PLK1 inhibitors on erythropoiesis.

View Article and Find Full Text PDF

Aims: Blood levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) may be modified by low renal clearance and anaemia. The aim of this study was to investigate the impact of the blood NT-proBNP level on cardiovascular and renal outcomes in patients with these two manifestations.

Methods: This post hoc analysis stemmed from the oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN) trial, a large prospective study involving patients with non-dialysis kidney disease experiencing anaemia.

View Article and Find Full Text PDF
Article Synopsis
  • Short-term heat acclimation (HA) for trained athletes boosts sweating adaptations and thermal resilience, but prolonged HA is better for benefits in cooler conditions and red blood cell production.
  • In a study with 20 elite cyclists, those undergoing 5 weeks of HA saw significant improvements in exhaustion time, sweat rates, and reduced sodium concentration after intense heat exposure.
  • However, these benefits diminished quickly after a 2-week break from HA, indicating that while short-term acclimation is effective, the endurance gains may not last long without continued practice.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effectiveness and safety of using vadadustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor, as an alternative to the erythropoiesis-stimulating agent methoxy polyethylene glycol-epoetin beta (MPG-EPO) in treating anemia for patients with chronic kidney disease (CKD) who are on dialysis.
  • This Phase 3b trial involved 456 adult participants, randomized into three groups receiving either vadadustat (at two different doses) or MPG-EPO, for up to 52 weeks, with a focus on changes in hemoglobin levels.
  • Results showed that vadadustat was noninferior to MPG-EPO regarding hemoglobin change
View Article and Find Full Text PDF

DDIT4 promotes erythroid differentiation and coordinates with SIPA1 to regulate erythroid proliferation in bone marrow of high altitude erythrocytosis.

Life Sci

December 2024

Key Laboratory of High Altitude and Frigid zone Medical Support, Chongqing, China; Key Laboratory of Extreme Environmental Medicine, Ministry of Education, Chongqing, China. Electronic address:

Erythrocytosis moderately enhances the oxygen-carrying capacity of the blood and is considered a characteristic response of individuals adapting from low-altitude regions to high-altitude regions. Nevertheless, erythrocytosis can also turn excessive and result in maladaptive syndromes, such as high altitude polycythemia (HAPC). The increased differentiation or proliferation of erythroid cells in the bone marrow may be a crucial factor leading to accumulation of peripheral erythroid cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!